154 related articles for article (PubMed ID: 31025818)
21. Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.
Boese EA; Jain N; Jia Y; Schlechter CL; Harding CO; Gao SS; Patel RC; Huang D; Weleber RG; Gillingham MB; Pennesi ME
Ophthalmology; 2016 Oct; 123(10):2183-95. PubMed ID: 27491397
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Novel HADHB Gene Mutation in an Iranian Patient with Mitochondrial Trifunctional Protein Deficiency.
Shahrokhi M; Shafiei M; Galehdari H; Shariati G
Arch Iran Med; 2017 Jan; 20(1):22-27. PubMed ID: 28112527
[TBL] [Abstract][Full Text] [Related]
23. Thermo-sensitive mitochondrial trifunctional protein deficiency presenting with episodic myopathy.
Schwantje M; Ebberink MS; Doolaard M; Ruiter JPN; Fuchs SA; Darin N; Hedberg-Oldfors C; Régal L; Donker Kaat L; Huidekoper HH; Olpin S; Cole D; Moat SJ; Visser G; Ferdinandusse S
J Inherit Metab Dis; 2022 Jul; 45(4):819-831. PubMed ID: 35403730
[TBL] [Abstract][Full Text] [Related]
24. Neurological outcome in long-chain hydroxy fatty acid oxidation disorders.
Mütze U; Ottenberger A; Gleich F; Maier EM; Lindner M; Husain RA; Palm K; Beblo S; Freisinger P; Santer R; Thimm E; Vom Dahl S; Weinhold N; Grohmann-Held K; Haase C; Hennermann JB; Hörbe-Blindt A; Kamrath C; Marquardt I; Marquardt T; Behne R; Haas D; Spiekerkoetter U; Hoffmann GF; Garbade SF; Grünert SC; Kölker S
Ann Clin Transl Neurol; 2024 Apr; 11(4):883-898. PubMed ID: 38263760
[TBL] [Abstract][Full Text] [Related]
25. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A case report.
Llorca-Cardeñosa A; Català-Mora J; García-Cazorla A; Meavilla S; Castejón-Ponce E
Arch Soc Esp Oftalmol; 2016 May; 91(5):236-9. PubMed ID: 26896063
[TBL] [Abstract][Full Text] [Related]
26. Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein.
Ojala T; Nupponen I; Saloranta C; Sarkola T; Sekar P; Breilin A; Tyni T
Eur J Pediatr; 2015 Dec; 174(12):1689-92. PubMed ID: 26070998
[TBL] [Abstract][Full Text] [Related]
27. Retinitis pigmentosa as a clinical presentation of LCHAD deficiency: A clinical case and review of the literature.
García García LC; Zamorano Martín F; Rocha de Lossada C; García Lorente M; Luque Aranda G; Escudero Gómez J
Arch Soc Esp Oftalmol (Engl Ed); 2021 Sep; 96(9):496-499. PubMed ID: 34479707
[TBL] [Abstract][Full Text] [Related]
28. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
Rigaudière F; Delouvrier E; Le Gargasson JF; Milani P; Ogier de Baulny H; Schiff M
Doc Ophthalmol; 2021 Jun; 142(3):371-380. PubMed ID: 33392894
[TBL] [Abstract][Full Text] [Related]
29. Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria.
Tonin AM; Amaral AU; Busanello EN; Grings M; Castilho RF; Wajner M
J Bioenerg Biomembr; 2013 Feb; 45(1-2):47-57. PubMed ID: 23065309
[TBL] [Abstract][Full Text] [Related]
30. Deregulation of mitochondrial functions provoked by long-chain fatty acid accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial permeability transition deficiencies in rat heart--mitochondrial permeability transition pore opening as a potential contributing pathomechanism of cardiac alterations in these disorders.
Cecatto C; Hickmann FH; Rodrigues MD; Amaral AU; Wajner M
FEBS J; 2015 Dec; 282(24):4714-26. PubMed ID: 26408230
[TBL] [Abstract][Full Text] [Related]
31. Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.
Schwantje M; Mosegaard S; Knottnerus SJG; van Klinken JB; Wanders RJ; van Lenthe H; Hermans J; IJlst L; Denis SW; Jaspers YRJ; Fuchs SA; Houtkooper RH; Ferdinandusse S; Vaz FM
FASEB J; 2024 Feb; 38(4):e23478. PubMed ID: 38372965
[TBL] [Abstract][Full Text] [Related]
32. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
Han Y; Yang Z; Ding X; Yu H; Yi Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
[TBL] [Abstract][Full Text] [Related]
33. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).
Karall D; Brunner-Krainz M; Kogelnig K; Konstantopoulou V; Maier EM; Möslinger D; Plecko B; Sperl W; Volkmar B; Scholl-Bürgi S
Orphanet J Rare Dis; 2015 Feb; 10():21. PubMed ID: 25888220
[TBL] [Abstract][Full Text] [Related]
35. Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency.
Hickmann FH; Cecatto C; Kleemann D; Monteiro WO; Castilho RF; Amaral AU; Wajner M
Biochim Biophys Acta; 2015; 1847(6-7):620-8. PubMed ID: 25868874
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts.
Lefort B; Gouache E; Acquaviva C; Tardieu M; Benoist JF; Dumas JF; Servais S; Chevalier S; Vianey-Saban C; Labarthe F
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1292-1299. PubMed ID: 28392417
[TBL] [Abstract][Full Text] [Related]
37. Collapsing glomerulopathy in a child with LCHAD deficiency: a rare association.
Kumar G; Nair R; Hendawy BS; AlShkeili OA; Alabdouli AA; Ali AMA; AlTenaiji AMJ
CEN Case Rep; 2019 Aug; 8(3):173-177. PubMed ID: 30747351
[TBL] [Abstract][Full Text] [Related]
38. Clinical course and cardiovascular outcomes in patients with the long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
Kwiatkowska J; Wierzba J; Karaszewska A; Kozlowski D; Sykut-Cegielska J; Stanko A
Cardiol J; 2017; 24(1):101-104. PubMed ID: 28245050
[No Abstract] [Full Text] [Related]
39. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function.
Fahnehjelm KT; Liu Y; Olsson D; Amrén U; Haglind CB; Holmström G; Halldin M; Andreasson S; Nordenström A
Acta Paediatr; 2016 Dec; 105(12):1451-1460. PubMed ID: 27461099
[TBL] [Abstract][Full Text] [Related]
40. Energy exchangers with LCT as a precision method for diet control in LCHADD.
Mozrzymas R; Konikowska K; Regulska-Ilow B
Adv Clin Exp Med; 2017; 26(3):515-525. PubMed ID: 28791828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
